Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 
Category: Endocrinology | Gynecology | Neurology | Pediatrics | Psychiatry | News

Back to Health News

Hormones May Affect Neurological Disease Risk

Last Updated: June 30, 2009.

 

Women are more vulnerable during certain stages of life, study finds

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Women are more vulnerable during certain stages of life, study finds.

TUESDAY, June 30 (HealthDay News) -- Fluctuating hormone levels may explain trends in the timing of women's susceptibility to neurological diseases such as Parkinson's, schizophrenia, Alzheimer's, Tourette's and attention-deficit/hyperactivity disorder, new research suggests.

Significant estrogen level changes occur at various stages of women's lives, including adolescence and menopause, and as a result of menstrual cycles. The onset or exacerbation of neurological diseases are most likely to occur at these times, said researchers at the University of Texas Medical Branch.

They found that a number of estrogens acting through their receptors affect the dopamine transporter (DAT). Dopamine is a neurotransmitter in the brain that plays an important role in normal functioning of the central nervous system.

"The significance of estrogen-coupled regulation of the DAT by both direct and indirect (kinase-mediated) interactions between estrogen receptors and the DAT should provide insights into how neurological diseases which involve the DAT are related to developmental, gender and life-stage issues," study author Cheryl Watson said in a news release from BioMed Central.

"Such regulation may suggest new ideas about treatment and prevention of diseases associated with extreme hormonal fluctuations, such as in postpartum depression," she added.

The study was published online in the journal BMC Neuroscience.

More information

The U.S. National Institute of Neurological Disorders and Stroke outlines neurological diagnostic tests and procedures.

SOURCE: BioMed Central, news release, June 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: Assessment of Bone Growth Stimulator Is Mixed Next: FDA Panel Urges Ban on Vicodin, Percocet

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.